Connect with us

Headlines of The Day

Q3 FY24- Dr. Lal PathLabs posts 54% jump in profit

Dr Lal PathLabs Limited announced their financial results for the quarter ended December 31, 2023.

Revenue increased by 10.1%. EBITDA increased by 24.6% with a margin of 26.1%; and PAT increased by 53.3% with a margin for of 15.3% in Q3 FY24 over Q2 FY23.

Financial overview (Consolidated)
(Rs Cr)

MB Bureau

Copyright © 2024 Medical Buyer

error: Content is protected !!